Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

On Friday, former FDA Commissioner and current Pfizer board member Dr. Scott Gottlieb appeared on CNBC’s “Squawk Pod” to discuss COVID-19 and the latest variant, a sub-variant of Omicron.

When asked what Americans should know about the latest variant, Gottlieb said that there are three questions. First, “is it more contagious?”

 

Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

EU Needs Geopolitical Muscle

EU foreign policy chief Josep Borrell says that the fall of…
Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Bank of America, Lowe’s Sponsored CRT Training

Bank of America, Lowe's, and Truist Financial Corporation sponsored…
Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Quad Plans Joint Naval Exercises

India, the US, Australia and Japan - members of the Washington-led…